(Q51561302)

7 April 2018

title

Effect of meal timing not critical for the pharmacokinetics of tegaserod (HTF 919). (English)

1 reference

7 April 2018

1 reference

Zhou H

1

1 reference

7 April 2018

Khalilieh S

2

1 reference

7 April 2018

Lau H

3

1 reference

7 April 2018

Guerret M

4

1 reference

7 April 2018

Osborne S

5

1 reference

7 April 2018

Alladina L

6

1 reference

7 April 2018

Laurent AL

7

1 reference

7 April 2018

McLeod JF

8

1 reference

7 April 2018

publication date

1 September 1999

1 reference

7 April 2018

The Journal of Clinical Pharmacology

published in

1 reference

7 April 2018

volume

39

1 reference

7 April 2018

issue

9

1 reference

7 April 2018

page(s)

911-919

1 reference

7 April 2018

The serotonin 5-HT4 receptor. 1. Design of a new class of agonists and receptor map of the agonist recognition site.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008524

The serotonin 5-HT4 receptor. 2. Structure-activity studies of the indole carbazimidamide class of agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008524

Serotonin receptors: subtypes, functional responses and therapeutic relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008524

Comparison of the Akaike Information Criterion, the Schwarz criterion and the F test as guides to model selection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008524

Pharmacokinetic absorption plots from oral data alone or oral/intravenous data and an exact Loo-Riegelman equation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008524

Absolute bioavailability, rate of absorption, and dose proportionality of sulpiride in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008524

Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008524

First pharmacokinetic-pharmacodynamic study in humans with a selective 5-hydroxytryptamine4 receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008524

10.1177/00912709922008524

21 January 2018

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

10471981

1 reference

7 April 2018